Search Results 721-730 of 4897 for 搜索留痕最新技术咨询邮箱：lgooxc@hotmail.com
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma. Blood Adv. 2025 May 13; 9(9):2336-2340. View ...
Mayo Clinic researcher Linda X. Yin, M.D., focuses on clinical trial development and patient-centered outcomes research.
Susanne G. Warner, M.D., researches minimally invasive surgical techniques, racial and gender bias in the profession of surgery, and oncolytic ...
The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial ...
2. To examine the safety and efficacy of initial alemtuzumab treatment in this study for patients who received Rebif® (interferon beta-1a) as their study ...
Collaborators. Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer.
Minimal residual disease (MRD) detection using circulating tumor DNA (ctDNA). MRD detection from proximal biofluids to anticipate cancer relapse.
About this study. Capsular REpair randomiSed controlled Trial (CREST) is a multi-center, randomized controlled trial with a sample size of 240 patients (120 ...
The secondary goal is to correlate SVV errors with standardized measures of discomfort with space-motion stimuli, dizziness handicap, anxiety, body vigilance, ...
The purpose of this study is to evaluate the effectiveness and safety of mepolizumab adjunctive therapy in participants with severe eosinophilic asthma by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.